BXP Completes Partial Sale of AstraZeneca Research Center
Boston Properties completed its partial sale of a Kendall Square life science project that values the two-building development at over $2,000 per square foot.
Discovery by Design at AstraZeneca’s New R&D Facility
This 570,000-square-foot tower will accommodate up to 1,850 employees after it opens in 2026. Teams from AstraZeneca and Alexion Rare Disease will collaborate here to transform the future of healthcare.
Alexandria Buys Astrazeneca Campus for $273M
Astrazeneca Pharmaceuticals sold its 43-acre campus in Waltham for $273 million as it prepares to depart for a Kendall Square development.
Lab Rents Dip in Seaport, Cambridge
Asking rents for lab space in two of the highest-priced local submarkets – Cambridge and Boston’s Seaport District – dipped in the second quarter amid an uptick in subleasing activity.
Cambridge Retains Lab Market Lead
Life science landlords continue to enjoy the upper hand in Greater Boston as the vacancy rate for the nearly 35 million-square-foot lab market remains below 3 percent, according to Colliers International research.
Kendall Square Development Gets First Tenant
Astrazenica’s 570,000-square-foot lease at 290 Binney St. in Cambridge represents the first tenant to commit to Boston Properties’ mixed-use redevelopment of its Blue Garage property in Kendall Square, while potentially creating new opportunities for life science companies to grow in Boston’s Seaport District and Waltham.
